Dimerix Limited (SBMJF)
OTCMKTS · Delayed Price · Currency is USD
0.3500
+0.1000 (40.00%)
At close: Jun 4, 2025
Dimerix Market Cap
Dimerix has a market cap or net worth of $212.45 million as of September 18, 2025. Its market cap has increased by 31.90% in one year.
Market Cap
212.45M
Enterprise Value
167.34M
Revenue
3.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.35
Market Cap Chart
Since July 6, 2015, Dimerix's market cap has increased from 9.95M to 212.45M, an increase of 2,035.76%. That is a compound annual growth rate of 34.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2025 | 212.45M | 80.99% |
| Dec 31, 2024 | 117.38M | 97.14% |
| Dec 29, 2023 | 59.54M | 88.29% |
| Dec 30, 2022 | 31.62M | -44.68% |
| Dec 31, 2021 | 57.16M | 59.34% |
| Dec 31, 2020 | 35.87M | 116.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Tian'an Technology Group | 792.01M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 735.19M |
| Glass House Brands | 548.40M |
| Northwest Biotherapeutics | 373.88M |
| CytoDyn | 351.92M |
| American Oncology Network | 345.48M |